Tag: pain

May 23, 2018

CSE Cannabis Stocks

INN offers investors a growing list of all cannabis-related companies listed on the CSE.
May 22, 2018

5 Top Weekly NASDAQ Biotech Stocks: Eiger BioPharmaceuticals Leads with 81.62 Percent

Eiger BioPharmaceuticals, Arqule, Galectin Therapeutics, MEI Pharma and BioDelivery Sciences were last week's top gainers on the NASDAQ.
May 20, 2018

Cannabis Weekly Round-Up: Aurora Wants to Buy MedReleaf for C$3.2 Billion

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
May 14, 2018

Canadian Cannabis Stocks

The Canadian cannabis space is one of the hottest growing sectors. Here's a look at Canadian cannabis stocks for investors...
May 13, 2018

5 Top Weekly NASDAQ Biotech Stocks: Helius Up 43.19 Percent

Helius Medical Technologies, vTv Therapeutics, Second Sight Medical Products, Depomed and Senomyx were last week's top gainers on the NASDAQ.
May 10, 2018

Aquinox and Astellas Announce Exclusive Licensing Agreement for Rosiptor in the Asia-Pacific Region Including Japan

Aquinox Pharmaceuticals (NASDAQ:AQXP) a clinical-stage pharmaceutical company discovering and developing novel drug candidates to treat inflammation, inflammatory pain, and blood...
May 10, 2018

Endonovo Therapeutics Signs Distribution Agreement with Plagens Medical Consultants for its Pain Relief Electroceutical SofPulse

Endonovo Therapeutics (OTCQB: ENDV) a commercial-stage developer of Electroceutical Therapies, today announced a distribution agreement with Plagens Medical Consultants for the...
May 10, 2018

Phivida Corporate Update for Fiscal Q2 2018

Phivida [“fiii-vee-daa”] Holdings Inc (CSE:VIDA) is pleased to provide a corporate update for the second quarter of fiscal 2018.
May 9, 2018

INSYS Therapeutics Announces Exclusive License Partnership with Lunatus to Commercialize SUBSYS® (fentanyl sublingual spray) in the Middle East

INSYS Therapeutics (NASDAQ:INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, announced today that...
May 8, 2018

Aquinox Pharmaceuticals Announces First Quarter 2018 Financial Results

Aquinox Pharmaceuticals (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing novel drug candidates to treat inflammation, inflammatory pain, and blood cancers,...